| Literature DB >> 26479377 |
Rabin Gyawali1, Radiah C Minor2, Barry Donovan3, Salam A Ibrahim4.
Abstract
The objectives of this study were to (i) investigate the impact of feeding oat on the population of bifidobacteria and (ii) evaluate their probiotic potential. In this study, we investigated the effects of supplementing sows' gestation and lactation feed with 15% oat (prebiotic source) on the levels of probiotic population in milk. We found that dietary inclusion of oat during lactation and gestation resulted in increased levels of bifidobacteria compared to lactobacilli in sow milk. Furthermore bifidobacteria within the sow milk samples were further evaluated for probiotic potential based on aggregating properties, and acid- and bile-tolerance after exposure to hydrochloric acid (pH 2.5) and bile salts (0%, 0.25%, 0.50%, 1.0% and 2.0%). All isolates survived under the condition of low pH and bile 2.0%. Autoaggregation ability ranged from 17.5% to 73%. These isolates also showed antimicrobial activity against E. coli O157:H7.Together our results suggest that inclusion of oat in feeding systems could have the potential to improve the intestinal health of piglets by increasing the population of bifidobacteria.Entities:
Keywords: bifidobacteria; characterization; isolation; oat; probiotic; sow milk
Year: 2015 PMID: 26479377 PMCID: PMC4598697 DOI: 10.3390/ani5030375
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Feed formulation.
|
|
| |
|
|
| |
| 11102 NCDA Corn (Rolled) | 80.3 | 65.38 |
| Soybean Meal | 13.8 | 13.8 |
| Ground Whole Oat 15% | 0 | 15 |
| Corn (1/8) Micro-Flush | 1 | 1 |
| Limestone Fine | 1.11 | 1.11 |
| MON-CAL 21% P | 2.05 | 2.05 |
| Salt | 0.5 | 0.5 |
| Swine TM PX (KSU) | 0.15 | 0.15 |
| Swine Sow-Pig VIT | 0.04 | 0.04 |
| Poultry Fat | 1 | 1 |
|
|
| |
|
|
| |
| Corn NCDA | 73 | 64.8 |
| Soybean Meal 48% | 17.6 | 10.8 |
| Ground Whole Oat 15% | 0 | 15 |
| Corn (1/8) Micro-Flush | 1 | 1 |
| Limestone Fine | 1.08 | 1.08 |
| MON-CAL 21% P | 2.38 | 2.38 |
| L-Lysine 50% | 0.25 | 0.25 |
| Salt | 0.5 | 0.5 |
| Threonine | 0.01 | 0.01 |
| Swine TM Prmx (KSU) | 0.15 | 0.15 |
| Swine VTM Prmx | 0.04 | 0.04 |
| Poultry Fat | 3.99 | 3.99 |
Figure 1Comparison of bifidobacteria and Lactobacillus present in sow milk collected each week for three weeks post birth during trial 1 and trial 2. Each bar is an average of an n = 6.
Figure 2Macroscopic view of (A) autoaggregation and (B) antimicrobial property of tested isolate.
Autoaggregation and antimicrobial activity of tested isolates.
| Isolate No. | Autoaggregation (%) | Zone of Inhibition (mm) |
|---|---|---|
| 1 | Nonaggregating | 10.0 ± 0.06 |
| 2 | Nonaggregating | 8.0 ± 0.07 |
| 3 | 17.5 ± 2.12 | 9.0 ± 0.04 |
| 4 | 25.5 ± 2.12 | 9.0 ± 0.06 |
| 5 | 68.0 ± 1.41 | 11.0 ± 0.04 |
| 6 | 45.5 ± 3.53 | 9.0 ± 0.08 |
| 7 | 62.0 ± 2.82 | 8.0 ± 0.06 |
| 8 | 73.0 ± 2.80 | 8.0 ± 0.04 |
| 9 | 66.0 ± 1.41 | 10.0 ± 0.05 |
| 10 | 60.5 ± 2.12 | 10.0 ± 0.03 |
| 11 | 51.0 ± 2.82 | 10.0 ± 0.04 |
| 12 | 63.5 ± 2.12 | 9.0 ± 0.05 |
| 13 | 64.0 ± 1.41 | 6.0 ± 0.06 |
| 14 | 25.0 ± 3.50 | 10.0 ± 0.03 |
The values are the averages of duplicate analysis ± S.D.
Bile tolerance of the isolates observed by turbidity readings (O.D. 610 nm) after 12 h of incubation at 37 °C.
| Isolate No. | Bile (%) | ||||
|---|---|---|---|---|---|
| 0% | 0.25% | 0.50% | 1.00% | 2.00% | |
| 1 | 0.98 ± 0.04 | 0.73 ± 0.04 | 0.54 ± 0.08 | 0.48±0.07 | 0.41 ± 0.11 |
| 2 | 0.95 ± 0.04 | 0.70 ± 0.08 | 0.47 ± 0.04 | 0.41±0.08 | 0.35 ± 0.12 |
| 3 | 0.93 ± 0.01 | 0.71 ± 0.08 | 0.51 ± 0.01 | 0.36±0.07 | 0.27 ± 0.08 |
| 4 | 0.82 ± 0.11 | 0.65 ± 0.01 | 0.46 ± 0.01 | 0.37±0.04 | 0.33 ± 0.10 |
| 5 | 0.93 ± 0.06 | 0.81 ± 0.03 | 0.68 ± 0.03 | 0.62±0.04 | 0.45 ± 0.11 |
| 6 | 1.02 ± 0.04 | 0.73 ± 0.04 | 0.72 ± 0.02 | 0.60±0.04 | 0.51 ± 0.05 |
| 7 | 1.01 ± 0.08 | 0.82 ± 0.04 | 0.74 ± 0.04 | 0.61±0.03 | 0.48 ± 0.04 |
| 8 | 0.96 ± 0.02 | 0.82 ± 0.03 | 0.73 ± 0.04 | 0.68±0.05 | 0.51±0.05 |
| 9 | 0.94 ± 0.06 | 0.74 ± 0.04 | 0.64 ± 0.04 | 0.65 ± 0.07 | 0.57 ± 0.04 |
| 10 | 0.89 ± 0.07 | 0.69 ± 0.04 | 0.53 ± 0.04 | 0.48 ± 0.01 | 0.43 ± 0.02 |
| 11 | 0.90 ± 0.05 | 0.72 ± 0.01 | 0.52 ± 0.05 | 0.43 ± 0.04 | 0.38 ± 0.04 |
| 12 | 0.85 ± 0.05 | 0.69 ± 0.01 | 0.54 ± 0.03 | 0.42 ± 0.04 | 0.36 ± 0.04 |
| 13 | 1.03 ± 0.18 | 0.95 ± 0.04 | 0.58 ± 0.02 | 0.53 ± 0.03 | 0.34 ± 0.04 |
| 14 | 1.01± 0.11 | 0.71 ± 0.04 | 0.56 ± 0.02 | 0.47 ± 0.02 | 0.41 ± 0.04 |
| Average | 0.94 ± 0.07 a | 0.75 ± 0.03 b | 0.59 ± 0.04 c | 0.51 ± 0.04 d | 0.41 ± 0.03 e |
The values are the averages of duplicate analysis ± S.D. Average values with the different superscript letters indicate significant difference (p < 0.05).
Population (Log CFU/mL) of isolates before and after 90 min of incubation at pH 6.5 or 2.5 at 37 °C.
| Isolate No. | pH 6.5 | pH 2.5 | ||
|---|---|---|---|---|
| 0 min | 90 min | 0 min | 90 min | |
| 1 | 7.32 ± 0.13 | 7.72 ± 0.12 | 7.31 ± 0.02 | 2.83 ± 0.03 |
| 2 | 7.07 ± 0.06 | 7.74 ± 0.04 | 6.84 ± 0.06 | 2.63 ± 0.14 |
| 3 | 7.14 ± 0.03 | 7.41 ± 0.02 | 6.48 ± 0.07 | 2.35 ± 0.15 |
| 4 | 6.63 ± 0.04 | 7.21 ± 0.01 | 6.48 ± 0.02 | 2.65 ± 0.14 |
| 5 | 9.37 ± 0.24 | 9.41 ± 0.10 | 9.24 ± 0.05 | 3.87 ± 0.04 |
| 6 | 9.56 ± 0.08 | 9.77 ± 0.02 | 9.42 ± 0.04 | 3.31 ± 0.19 |
| 7 | 9.47 ± 0.11 | 9.56 ± 0.17 | 9.41 ± 0.09 | 2.70 ± 0.15 |
| 8 | 9.49 ± 0.04 | 9.51 ± 0.05 | 9.27 ± 0.10 | 3.30 ± 0.04 |
| 9 | 8.46 ± 0.02 | 8.73 ± 0.07 | 8.39 ± 0.10 | 2.64 ± 0.09 |
| 10 | 8.36 ± 0.04 | 8.62 ± 0.19 | 8.17 ± 0.05 | 2.67 ± 0.16 |
| 11 | 8.74 ± 0.05 | 8.80 ± 0.03 | 8.26 ± 0.06 | 3.34 ± 0.06 |
| 12 | 8.33 ± 0.10 | 8.88 ± 0.19 | 8.08 ± 0.13 | 4.06 ± 0.02 |
| 13 | 9.01 ± 0.01 | 9.18 ± 0.07 | 8.11 ± 0.04 | 4.93 ± 0.03 |
| 14 | 8.18 ± 0.02 | 9.00 ± 0.08 | 7.93 ± 0.10 | 4.01 ± 0.07 |
| Average | 8.36 ± 0.07 | 8.68 ± 0.08 | 8.10 ± 0.07 | 3.23 ± 0.09 |
The values are the averages of duplicate analysis ± S.D.
Figure 3Growth of isolates in MRS broth after 90 min of incubation at pH (A) 6.5 and (B) 2.5.
Antibiotic susceptibility of different isolates.
| Antibiotics (mg/L) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Isolate No. |
|
|
|
| ||||
| 4 | 5 | 5 | 6 | 1 | 2 | 65 | 66 | |
|
| S | S | S | S | S | S | R | R |
|
| S | S | S | S | R | R | R | R |
|
| S | S | S | S | R | R | R | R |
|
| S | S | S | S | R | R | R | R |
|
| S | S | S | S | R | R | R | R |
|
| S | S | S | S | R | R | R | R |
|
| S | S | S | S | R | R | R | R |
|
| S | S | S | S | S | S | R | R |
|
| S | S | S | S | R | R | R | R |
|
| S | S | S | S | R | R | R | R |
|
| S | S | S | S | R | R | R | R |
|
| S | S | S | S | S | S | R | R |
|
| S | S | S | S | S | S | R | R |
|
| S | S | S | S | S | S | R | R |
Antibiotic concentrations were selected based on microbiological breakpoints values (mg/L) for Bifidobacterium spp. [12]. S-Sensitive, R-Resistant.